PLA2G4A Antikörper (AA 1-110)
(1 reference)Kurzübersicht für PLA2G4A Antikörper (AA 1-110) (ABIN562257)
Target
Alle PLA2G4A Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-110
-
Verwendungszweck
- Mouse polyclonal antibody raised against a partial recombinant PLA2G4A.
-
Sequenz
- MSFIDPYQHI IVEHQYSHKF TVVVLRATKV TKGAFGDMLD TPDPYVELFI STTPDSRKRT RHFNNDINPV WNETFEFILD PNQENVLEIT LMDANYVMDE TLGTATFTVS
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- PLA2G4A (NP_077734, 1 a.a. ~ 110 a.a) partial recombinant protein with GST tag.
-
-
anti-Phospholipase A2, Group IVA (Cytosolic, Calcium-Dependent) (PLA2G4A) (AA 563-749) antibody
PLA2G4A Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Phospholipase A2, Group IVA (Cytosolic, Calcium-Dependent) (PLA2G4A) (N-Term) antibodyPLA2G4A Reaktivität: Human, Maus, Ratte WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Phospholipase A2, Group IVA (Cytosolic, Calcium-Dependent) (PLA2G4A) (AA 1-178) antibodyPLA2G4A Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Phospholipase A2, Group IVA (Cytosolic, Calcium-Dependent) (PLA2G4A) (AA 1-178) antibodyPLA2G4A Reaktivität: Human WB, IHC Wirt: Maus Monoclonal C19 unconjugated
anti-Phospholipase A2, Group IVA (Cytosolic, Calcium-Dependent) (PLA2G4A) (AA 513-541) antibodyPLA2G4A Reaktivität: Human WB, IF, IHC (p), FACS Wirt: Kaninchen Polyclonal RB21320 unconjugated
anti-Phospholipase A2, Group IVA (Cytosolic, Calcium-Dependent) (PLA2G4A) (pSer505) antibodyPLA2G4A Reaktivität: Human, Maus, Ratte WB, IHC, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Phospholipase A2, Group IVA (Cytosolic, Calcium-Dependent) (PLA2G4A) (Internal Region) antibodyVerified PLA2G4A Reaktivität: Human WB, IHC, ELISA, IF, FACS Wirt: Ziege Polyclonal unconjugated
anti-Phospholipase A2, Group IVA (Cytosolic, Calcium-Dependent) (PLA2G4A) (AA 379-533) antibodyPLA2G4A Reaktivität: Human IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Phospholipase A2, Group IVA (Cytosolic, Calcium-Dependent) (PLA2G4A) antibodyPLA2G4A Reaktivität: Human, Maus, Ratte IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Phospholipase A2, Group IVA (Cytosolic, Calcium-Dependent) (PLA2G4A) (AA 1-180) antibodyPLA2G4A Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 50 % glycerol
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
: "Reduced group IVA phospholipase A2 expression is associated with unfavorable outcome for patients with gastric cancer." in: Medical oncology (Northwood, London, England), Vol. 30, Issue 1, pp. 454, (2013) (PubMed).
-
: "Reduced group IVA phospholipase A2 expression is associated with unfavorable outcome for patients with gastric cancer." in: Medical oncology (Northwood, London, England), Vol. 30, Issue 1, pp. 454, (2013) (PubMed).
-
- PLA2G4A (Phospholipase A2, Group IVA (Cytosolic, Calcium-Dependent) (PLA2G4A))
-
Andere Bezeichnung
- PLA2G4A
-
Hintergrund
-
Full Gene Name: phospholipase A2, group IVA (cytosolic, calcium-dependent)
Synonyms: MGC126350,PLA2G4,cPLA2-alpha -
Gen-ID
- 5321
-
NCBI Accession
- NM_024420
-
Pathways
- Inositol Metabolic Process, G-protein mediated Events, VEGF Signaling
Target
-
